Kevin Haas is the Chief Technology Officer at Myriad Genetics, where he leads cross-functional teams across engineering, digital health, AI, and genomics to drive innovation in precision medicine. With a background in chemical engineering and machine learning, Kevin has spearheaded transformative platforms that enhance clinical genetic testing, health data intelligence, and patient-provider digital engagement. He has played a central role in building scalable, automated lab and bioinformatics infrastructure that supports next-generation diagnostics and genomic services for millions of patients worldwide.
Before taking on the CTO role, Kevin held multiple leadership positions at Myriad Genetics, including SVP of Engineering and VP of Bioinformatics. His prior experience includes key engineering roles at Counsyl and deep contributions to life sciences software and AI. A Ph.D. graduate from UC Berkeley, Kevin is also a patent holder and published researcher in high-throughput genomics and prenatal screening. He is a recognized voice in health tech, contributing to industry conferences and publications, and has served as an advisor to biotech startups and as a board leader in national sporting organizations.